Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Significant Growth in Short Interest

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 23,534 shares, an increase of 202.1% from the December 31st total of 7,789 shares. Approximately 0.9% of the shares of the stock are short sold. Based on an average trading volume of 87,980 shares, the short-interest ratio is presently 0.3 days. Based on an average trading volume of 87,980 shares, the short-interest ratio is presently 0.3 days. Approximately 0.9% of the shares of the stock are short sold.

Invesco Nasdaq Biotechnology ETF Price Performance

IBBQ stock opened at $29.34 on Thursday. The company’s 50 day simple moving average is $28.73 and its 200-day simple moving average is $25.90. Invesco Nasdaq Biotechnology ETF has a 12 month low of $17.84 and a 12 month high of $30.13. The firm has a market capitalization of $72.76 million, a PE ratio of 17.03 and a beta of 0.67.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 26th. Shareholders of record on Monday, December 22nd were issued a dividend of $0.0906 per share. This represents a $0.36 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Monday, December 22nd.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

Institutional investors and hedge funds have recently made changes to their positions in the stock. MMA Asset Management LLC acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the third quarter valued at $51,000. Advisory Services Network LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the 3rd quarter valued at about $52,000. Osaic Holdings Inc. boosted its stake in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after purchasing an additional 1,052 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF during the second quarter worth about $149,000. Finally, IHT Wealth Management LLC acquired a new position in shares of Invesco Nasdaq Biotechnology ETF in the second quarter valued at approximately $211,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.